Hypomenorrhea due to cold-coagulation and blood-stagnation
Conditions
Interventions
Group 1:herbal cake-separated spreading moxibustion
Group 2:Normal herbal cake-separated moxibustion
Group 3:Waiting list, without treatment in waiting, and give same treatment after trial
Sponsors
Hangzhou Red Cross Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. Woman who meets the diagnosis criteria of disease and TCM syndrome; 2. Aged 18-40 years; 3. Has regular menstrual cycle with a period =7 days and 28±7 days cycle; 4. The woman who voluntarily participates in the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. The woman who long-term uses drugs that affect uterine blood flow; 2. The woman who has congenital uterine dysplasia, ovarian hypoplasia, endometrium tuberculosis, pelvic organ tissue malignancy, severe skin disease or mental disease; 3. The woman who is allergic to medicine cakes and cannot tolerate moxibustion; 4. The woman who can't to cooperate with examination and treatment; 5. The woman who has no sexual experience; 6. The woman who may reduce the possibility of enrollment or complicate enrollment, such as frequent changes of work and other circumstances that may easily lead to loss of follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Integral of TCM syndrome;The Integral of TCM syndrome; | — |
Secondary
| Measure | Time frame |
|---|---|
| The resistance index of arteriae uterina;Nitric oxide;Endothelins;The pulsatility index of arteriae uterina;The systolic/diastolic Moliu ratio of arteriae uterina;The whole blood viscosity at a high-shear rate;The whole blood viscosity at a low-shear rate;Aggregation of RBC;Haematocrit;The whole clinical effect;Safety;Compliance;The resistance index of arteriae uterina;Nitric oxide;Endothelins;The pulsatility index of arteriae uterina;The systolic/diastolic Moliu ratio of arteriae uterina;The whole blood viscosity at a high-shear rate;The whole blood viscosity at a low-shear rate;Aggregation of RBC;Haematocrit;The whole clinical effect;Safety;Compliance; | — |
Countries
China
Contacts
Public ContactJin Huifang
Hangzhou Red Cross Hospital
Outcome results
None listed